Wellco Health Limited - Appointment of Director an
WLL
WLL
Wellco Health Limited - Appointment of Director and Auditors
Wellco Health Limited
(formerly Nungu Trading 279 (Pty) Ltd)
(Incorporated in the Republic of South Africa)
(Registration number 2005/005805/06)
Share code: WLL & ISIN: ZAE000071841
("Wellco Health" or "the company")
APPOINTMENT OF DIRECTOR AND AUDITORS
In accordance with paragraph 3.59 of the JSE Listings Requirements the company
wishes to announce the appointment of Terrence Michael Wynne as an executive
director with effect from 1 November 2006.
The board also wishes to announce the appointment of Deloitte as auditors of the
company for the year ending 28 February 2007.
25 October
Pretoria
Designated Advisor
River Group
Warning: The listing of ordinary shares in the company is on the AltX.
Shareholders are advised of the risks of investing in a company listed on the
AltX. Shareholders are advised that the JSE does not guarantee the viability or
the success of a company listed on the AltX. In terms of the JSE Listings
Requirements a Designated Advisor has to be retained by the company. The
Designated Advisor is required to, inter alia, attend all board meetings held by
the company to ensure that all JSE Listings Requirements and applicable
regulations are complied with, approve the financial director of the company and
guide the company in a competent, professional and impartial manner. If the
company fails to retain a Designated Advisor it must make arrangement to appoint
a new Designated Advisor within 10 business days, failing which the company
faces suspension of trading of its securities. If a Designated Advisor is not
appointed within 30 days of its suspension the company faces the termination of
its listing without an offer to minority shareholders.
Date: 26/10/2006 07:00:23 AM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
